Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of TGF (Hu-Qian Wan) for Knee Osteoarthritis
NCT03562429Phase 3Unknown
- Sponsor
- China Medical University Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of Hu-Qian Wan in osteoarthritis (OA) (2 arms), sponsored by China Medical University Hospital. Primary endpoints: Western Ontario & McMaster Universities Osteoarthritis Index at 4 months, Visual Analogue Scale for pain at 4 months and 1 more. Status: unknown.
02
Drugs
Hu-Qian Wan
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03562429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03562429.